CD8(+)PD-1(+) to CD4(+)PD-1(+) ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers

Duchemann, B; Naigeon, M; Auclin, E; Ferrara, R; Cassard, L; Jouniaux, JM; Boselli, L; Grivel, J; Desnoyer, A; Danlos, FX; Mezquita, L; Caramella, C; Marabelle, A; Besse, B; Chaput, N

Chaput, N (通讯作者),Gustave Roussy, US23, INSERM, Lab Immunomonitoring Oncol,CNRS,UMS 3655, Villejuif, Ile De France, France.;Chaput, N (通讯作者),Univ Paris Saclay, Fac Pharm, Chatenay Malabry, Ile De France, France.

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022; 10 (2):